Biogenetics company Klotho Neurosciences has announced plans to acquire assets from Turn Biotechnologies, marking a move in ...
Patients gain access to AI-powered analysis, DNA-based protocols, and non-invasive treatments with 90%+ success rates Jacqueline Joy Battjes' commitment to functional and regenerative medicine aligns ...
Jacqueline Joy Battjes’ commitment to functional and regenerative medicine aligns perfectly with our mission to deliver effective, patient-focused care.” — Trace Herchman, President of GetHairMD ...
NEW YORK, Oct. 7, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho", or "the Company") today announced that its Letter of Intent with Turn Biotechnologies was allowed to expire ...
Under the LOI, Klotho would acquire Turn’s ERA (“Epigenetic Reprogramming of Age”) platform and eTurna RNA delivery system.
NEW YORK and PALO ALTO, Calif., Sept. 30, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho" or "the Company") today announced it has signed a Letter of Intent (LOI) to acquire ...
NEW YORK and PALO ALTO, Calif., Sept. 30, 2025 /PRNewswire/ -- Klotho Neurosciences, Inc. (Nasdaq: KLTO, "Klotho" or "the Company") today announced it has signed a Letter of Intent (LOI) to acquire ...